Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/44710
Title: FURTHER EXPLORATION OF ADRENOMEDULLIN AS A NOVEL THERAPEUTIC PEPTIDE FOR LUPUS NEPHRITIS USING MRL/FAS LPR MOUSE MODEL
Authors: KOW NIEN YEE
Keywords: Systemic lupus erythematosus, SLE, neprhitis, lupus, adrenomedullin, ADM
Issue Date: 25-Jan-2013
Source: KOW NIEN YEE (2013-01-25). FURTHER EXPLORATION OF ADRENOMEDULLIN AS A NOVEL THERAPEUTIC PEPTIDE FOR LUPUS NEPHRITIS USING MRL/FAS LPR MOUSE MODEL. ScholarBank@NUS Repository.
Abstract: Systemic lupus erythematosus (SLE) is an inflammatory autoimmune disease characterized by the production of a wide range of autoantibodies. The disease activity of SLE has been found to be correlated with the level of plasma adrenomedullin (ADM) in patients with SLE. ADM is a novel peptide that consists of 52 amino acids and was first identified in human phaeochromoctyoma. It has been demonstrated ADM is a potent vasodilator and plays an important role in mediating the immune system. The objective of this study was to investigate the effect of ADM on the disease progression of lupus-like disease and glomerular deposition of immune complexes in MRL/Faslpr autoimmune mice. Besides, the effect of ADM on cultured splenocytes extracted from MRL/Faslpr mice was also investigated. Results obtained suggested that ADM might play a role in regulating proliferation and apoptosis of the B lymphocytes, and the development of glomerulonephritis in establishing lupus-like disease.
URI: http://scholarbank.nus.edu.sg/handle/10635/44710
Appears in Collections:Master's Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
KowNY.pdf2.85 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

103
checked on Dec 11, 2017

Download(s)

22
checked on Dec 11, 2017

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.